Mblue Labs launches methylene blue hair regeneration serum

By AI, Created 10:22 AM UTC, May 20, 2026, /AGP/ – Mblue Labs launched Bluelene Hair Density Renewal Serum+ on May 7, 2026, introducing a methylene blue-based product aimed at hair follicle stem cells and scalp regeneration. The company says the serum targets oxidative stress and metabolic imbalance, with research positioning it as a potential option for emerging hair loss tied to GLP-1 therapies.

Why it matters: - Hair loss treatments often focus on stimulating existing follicles. Mblue Labs is betting on preserving the stem cells that drive long-term hair regeneration. - The product targets two major drivers of hair loss: oxidative stress and metabolic imbalance. - The launch also speaks to hair shedding linked to GLP-1 receptor agonists used for weight management. - Mblue Labs says the serum could fit as a standalone product, an add-on to current therapies or a support tool for hair transplant outcomes.

What happened: - Mblue Labs launched Bluelene Hair Density Renewal Serum+ on May 7, 2026. - The Bethesda, Maryland-based biotechnology company said the product uses methylene blue to support hair follicle stem cells. - The technology comes from research at the University of Maryland. - The company tied the launch to findings on hair loss, scalp health and stem cell protection. - Research published: the study - Clinical test results are posted on the science page

The details: - Mblue Labs says methylene blue has clinically studied mitochondrial and stem cell–protective properties. - The company says the molecule can improve cellular energy production, protect against UV-induced damage and support tissue regeneration. - The serum is designed to protect and activate hair follicle stem cells, or HFSCs. - Mblue Labs says the technology addresses oxidative stress and metabolic imbalance at the root of hair loss. - Research and clinical trial findings cited by Mblue Labs say methylene blue can enhance HFSC proliferation and viability. - The same findings say the molecule reduces reactive oxygen species, activates the Wnt/β-catenin signaling pathway and accelerates cellular repair. - Mblue Labs says methylene blue can also protect stem cells from metabolic stressors linked to GLP-1 therapies. - The company says the product may work with minoxidil by enhancing regenerative signaling. - Mblue Labs says lower-dose combination strategies could help reduce side effects. - The company also says the serum may be used as an adjunct therapy to improve hair transplant outcomes. - The research was funded under a Maryland Industrial Partnerships grant that supports product development between companies and University of Maryland faculty. - Bluelene Hair Density Renewal Serum+ is available through direct-to-consumer online channels, with Bluelene and Amazon coming soon. - The product is also being sold through select dermatology clinics and specialty retailers.

Between the lines: - Mblue Labs is trying to move methylene blue from an aging-biology ingredient into a scalp-health platform. - The framing suggests the company sees hair loss less as a follicle stimulation problem and more as a stem cell preservation problem. - The GLP-1 angle gives the launch a timely hook because weight-loss drugs have created a new conversation around treatment-associated hair shedding. - The University of Maryland link gives the product a research-backed story that may matter to clinicians and consumers weighing alternatives to existing hair-loss formulas.

What’s next: - Mblue Labs is pushing the product across online retail, dermatology clinics and specialty stores. - The company is also using published research and clinical test results to support broader adoption. - The launch positions Bluelene for further marketing around hair preservation, regenerative signaling and combination use with established treatments.

The bottom line: - Mblue Labs is launching a science-led hair serum built around methylene blue, with a pitch centered on stem cell protection rather than conventional follicle stimulation.